← All companies

GILD

Gilead Sciences, Inc.

GILD Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$131.15

+0.94 +0.72%

Key statistics

from XBRL data in SEC filings

Market cap

$163B

Revenue (TTM)

$29.7B

Net income (TTM)

$9.22B

EPS (TTM)

$7.35

P/E ratio

17.8

Dividend yield

2.43%

Free cash flow

$9.46B

Cash

$7.63B

Total assets

$56.3B

Gross margin

66.5%

52-week range

$108.46 – $157.29

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Took on a direct financial obligation; Other events May 20, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Shareholder vote results May 4, 2026 8-K Regulation FD disclosure; Other events Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Entered a material agreement; Regulation FD disclosure Feb 23, 2026 8-K Results of operations (earnings release) Feb 10, 2026 8-K Director or officer change Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Regulation FD disclosure Oct 6, 2025 8-K Director or officer change Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Amended charter or bylaws Aug 4, 2025 8-K Shareholder vote results May 8, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) Apr 24, 2025 8-K Director or officer change Mar 12, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release) Feb 11, 2025 8-K/A Director or officer change Dec 13, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Other events Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change Jul 17, 2024 8-K Amended charter or bylaws; Shareholder vote results May 9, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) Apr 25, 2024 8-K Regulation FD disclosure; Other events Mar 22, 2024 8-K Director or officer change Mar 14, 2024 10-K Fiscal year ended 2023-12-31 Feb 23, 2024 8-K Entered a material agreement; Other events Feb 12, 2024 8-K Results of operations (earnings release) Feb 6, 2024 8-K Director or officer change Feb 2, 2024 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023